SGEM#504: Home Where I Wanted to Go After Anaphylaxis

Determining safe observation periods for children following anaphylaxis treatment requires moving away from rigid, prolonged monitoring toward risk-stratified, shared decision-making. Evidence suggests that a two-hour observation period is sufficient for most pediatric patients who respond promptly to a single dose of intramuscular epinephrine. While biphasic reactions—the recurrence of symptoms without further allergen exposure—can occur up to 72 hours later, they are rare. Clinical management should focus on verifying the patient's durable response to initial therapy, confirming the family’s ability to recognize symptoms of recurrence, and ensuring they possess an epinephrine autoinjector before discharge. Pediatric emergency medicine fellow Dr. Kammeron Brissett emphasizes that while institutional guidelines vary, prioritizing clinical judgment and patient values over arbitrary timeframes improves care efficiency and reduces unnecessary emergency department boarding.